Ahead of print

Original article

Diagnostic and Potentially Prognostic Value of Novel Inflammatory Indices in Non-Arteritic Anterior Ischemic Optic Neuropathy

Full Text links

Summary

Aim: The aim of this study was to investigate the potential contribution of systemic inflammation to the pathogenesis of non-arteritic anterior ischemic optic neuropathy (NAION), to evaluate the diagnostic and potentially prognostic value of relatively novel inflammatory indices, and to assess their associations with visual function and structural optic nerve findings at presentation.

Materials and Methods: The medical records of 26 patients diagnosed with NAION and 28 age-, sex-, and comorbidity-matched controls were retrospectively reviewed. From complete blood count results obtained at diagnosis, platelet, neutrophil, lymphocyte, monocyte, and immature granulocyte counts were recorded, and the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), pan-immune inflammation value (PIV), systemic immune-inflammation index (SII), and systemic inflammatory response index (SIRI) were calculated. Baseline best-corrected visual acuity (BCVA), retinal nerve fiber layer (RNFL) thicknesses, and visual field parameters were also evaluated.

Results: In the NAION group, platelet and neutrophil counts, as well as NLR, PLR, PIV, SII, and SIRI values, were significantly higher than in controls (p < 0.05). ROC analysis revealed that PIV (AUC = 0.830) and SII (AUC = 0.812) demonstrated the highest discriminatory power. PIV, SII, SIRI, and NLR showed significant negative correlations with mean, superior, and nasal RNFL thickness (p < 0.05), whereas PLR did not correlate (p > 0.05).

Conclusion: Elevated inflammatory markers, including NLR, PLR, PIV, SII, and SIRI, indicate the potential role of systemic inflammation in NAION pathogenesis. PIV and SII, in particular, demonstrated strong predictive potential for diagnosis and were associated with baseline optic nerve damage.

References

  1. Katz DM, Trobe JD. Is there treatment for nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2015;26(6):458-
  2. Arnold A. Vascular supply of the optic nerve head: implications for optic disc ischaemia. Brit J Ophthalmol. 2023;107(5):595-599.
  3. Hayreh SS. Ischemic optic neuropathies - Where are we now? Graefe’s Arch Clin Exp Ophthalmol. 2013;251(8):1873-1884.
  4. Polat O, Yavaş GF, İnan S, İnan ÜÜ. Neutrophil-to-Lymphocyte Ratio as a Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy. Balkan Med J. 2015;32(4):382.
  5. Chen X, Liu H, Yue Y, Wang H. Hematological indicators and ocular parameters in patients with non-arteritic anterior ischemic optic neuropathy. Inter Ophthalmol. 2025 45:1. 2025;45(1):1-8.
  6. Koçak N, Eraydın B, Turun M, Yeter V, Güngor I. Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy. Korean J Ophthalmol. 2020;34(6):478.
  7. Uzakgider NK, Karaca Adiyeke S, Aytogan H. Understanding the Etiopathogenesis of Non-Arteritic Anterior Ischemic Optic Neuropathy with Laboratory Findings. Beyoglu Eye J. 2024;9(1):8-13.
  8. Imtiaz F, Shafique K, Mirza S, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5(1):2
  9. Zhang C, Wang H, Ning Z, et al. Prognostic value of systemic inflammatory response markers in patients with intrahepatic cholangiocarcinoma. Int J Clin Exp Med. 2016;9(6):11502-11509.
  10. Qin B, Ma N, Tang Q, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26(3):372-376.
  11. Pan L, Du J, Li T, Liao H. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu’s arteritis: a case-control study. BMJ Open. 2017;7(4):e014451.
  12. Canlı D. Evaluation of systemic immune-inflammation index, systemic inflammatory response index and hematologic inflammatory parameters in generalized anxiety disorder: a controlled study. Anatolian Current Medical Journal. 2024;6(2):161-
  13. Tarim B. The role of serum biomarkers in determining systemic inflammation and cardiovascular risk in pseudoexfoliation syndrome. Int Ophthalmol. 2025;45(1).
  14. Kates MM, Isen DR, Vaphiades MS, Kline LB. Pallid Optic Disc Edema in Nonarteritic Anterior Ischemic Optic Neuropathy. Journal of Neuro-Ophthalmology. 2025;45(2):e114-e116.
  15. Salgado C, Vilson F, Miller NR, Bernstein SL. Cellular Inflammation in Nonarteritic Anterior Ischemic Optic Neuropathy and Its Primate Model. Archives of Ophthalmology. 2011;129(12):1583-1591.
  16. Kashani E, Nourigheimasi S, Valisno J, et al. Diagnostic significance of neutrophil-to-lymphocyte ratio in non-arteritic anterior ischemic optic neuropathy: a meta-analysis. Eur J Med Res. 2024;29(1):562.
  17. Bernstein SL, Johnson MA, Miller NR. Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog Retin Eye Res. 2011;30(3):167-187.
  18. Wang Q, Zhong W, Xiao Y, et al. Pan-immune-inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer. Cancer Sci. 2025;116(2):350-366.
  19. Yolbas S, Yildirim A, Gozel N, Uz B, Koca SS. Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet’s Disease. Medical Principles and Practice. 2016;25(6):510.
  20. Ozgonul C, Sertoglu E, Mumcuoglu T, Kucukevcilioglu M. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Novel Biomarkers of Primary Open-Angle Glaucoma. J Glaucoma. 2016;25(10):e815-e820.
  21. Karaca EE, Özmen MC, Ekici F, Yüksel E, Türkoʇlu Z. Neutro - phil-to-lymphocyte ratio may predict progression in patients with keratoconus. Cornea. 2014;33(11):1168-1173.
  22. Elbeyli A, Kurtul BE, Ozcan DO, Ozcan SC, Dogan E. Assessment of Red Cell Distribution Width, Platelet/lymphocyte Ratio, Systemic Immune-inflammation Index, and Neutrophil/lymphocyte Ratio Values in Patients with Central Retinal Artery Occlusion. Ocul Immunol Inflamm. 2022;30(7-8):1940-1944.
  23. Liu Z, Perry LA, Penny-Dimri JC, et al. The association of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio with retinal vein occlusion: a systematic review and meta-analysis. Acta Ophthalmol. 2022;100(3):e635-e647. doi:10.1111/AOS.14955
  24. Timur İEE, Tarım B, Şeker ED, Uğurlu N. The relation between serum inflammatory marker levels and serous retinal detachment in macular edema secondary to retinal vein occlusion. Photodiagnosis Photodyn Ther. 2023;42:103591. doi:10.1016/j.pdpdt.2023.103591
  25. Bisgaard AK, Pihl-Jensen G, Frederiksen JL. The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis. Mult Scler Relat Disord. 2017;18:213-217. doi: 10.1016/j.msard.2017.10.009